People

Megan Dover is Partner and Co-founder of CBIV. Her experience spans impact investing, venture advisory, M&A, corporate strategy, finance and biomedical research. Before the firm’s launch she advised health technology companies and helped mobilize equity and non-dilutive funding. She holds an MBA from Rotman and an engineering degree from Queen’s specializing in biomedical research within chemical engineering.